Please Wait
Applying Filters...
menu
    • menu
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Minoxidil

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    An Enquiry

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Minoxidil

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    An Enquiry

    Menu

    Loniten

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Triple Hair Starts Phase 3 Dosing for Male Androgenetic Alopecia
    Triple Hair Starts Phase 3 Dosing for Male Androgenetic Alopecia

    02 Apr 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-04-02/triple-hair-doses-first-patient-in-phase-iii-clinical-trial-in-canada-for-male-androgenic-alopecia

    PHARMIWEB
    02 Apr 2026
    Share Share
    Glenmark Canada Launches Men's GLN-Minoxidil 5% Foam
    Glenmark Canada Launches Men's GLN-Minoxidil 5% Foam

    01 Apr 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/glenmark-pharmaceuticals-canada-inc-launches-mens-gln-minoxidil-5-ww-topical-aerosol-foam-in-canadian-retail-302730497.html

    PR NEWSWIRE
    01 Apr 2026
    Share Share
    Veradermics Finishes Phase 3 Trial Enrollment For VDPHL01
    Veradermics Finishes Phase 3 Trial Enrollment For VDPHL01

    09 Feb 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260209938753/en/Veradermics-Completes-Enrollment-in-Second-Pivotal-Phase-3-Clinical-Trial-of-VDPHL01-for-Male-Pattern-Hair-Loss

    BUSINESSWIRE
    09 Feb 2026
    Share Share
    Veradermics Advances VDPHL01 Trial For Male Pattern Hair Loss
    Veradermics Advances VDPHL01 Trial For Male Pattern Hair Loss

    11 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251211386584/en/Veradermics-Completes-Enrollment-in-its-Phase-23-Clinical-Trial-of-VDPHL01-for-Male-Pattern-Hair-Loss-Advancing-Development-of-the-Potential-First-Ever-Extended-Release-Oral-Minoxidil

    BUSINESSWIRE
    11 Dec 2025
    Share Share
    EDQM Issued CEP Certificate for Minoxidil
    EDQM Issued CEP Certificate for Minoxidil

    08 Dec 2025

    // PRESS RELEASE

    https://www.iolcp.com//uploads/Intimation05-12-2025.pdf

    PRESS RELEASE
    08 Dec 2025
    Share Share
    Veradermics VDPHL01 Enters Phase 2/3 for Female Pattern Hair Loss
    Veradermics VDPHL01 Enters Phase 2/3 for Female Pattern Hair Loss

    18 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251118317254/en/Veradermics-Advances-VDPHL01-in-Phase-23-Clinical-Trial-for-Female-Pattern-Hair-Loss-Marking-a-Milestone-in-the-Development-of-the-Potential-First-Ever-Oral-Prescription-Treatment-for-Women

    BUSINESSWIRE
    18 Nov 2025
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.